Related Experiment Video
Updated: Jun 13, 2026

A Protocol for Analyzing Hepatitis C Virus Replication
Published on: June 26, 2014
Distribution of different hepatitis C virus genotypes in patients with hepatitis C virus infection
Farah Bokharaei Salim1, Hossein Keyvani, Afsaneh Amiri
1GI and Liver Disease Research Centre, Iran University of Medical Sciences, Firouzgar Hospital, Valadi Street, Valiasr Square, Tehran, Iran.
Insights
Multiple hepatitis C virus (HCV) genotypes were detected in patients with chronic hepatitis C, with discrepancies observed between plasma, peripheral blood mononuclear cells (PBMCs), and liver biopsy specimens.
Area of Science:
- Hepatology
- Virology
- Infectious Diseases
Background:
- Chronic hepatitis C virus (HCV) infection is a significant global health concern.
- Understanding HCV genotype distribution is crucial for effective antiviral therapy.
- Mixed HCV infections can complicate diagnosis and treatment.
Purpose of the Study:
- To investigate the prevalence of mixed HCV infections.
- To determine discrepancies in HCV genotypes across different sample types: plasma, PBMCs, and liver biopsies.
- To assess the impact of sample source on HCV genotype detection.
Main Methods:
- Recruitment of 133 patients with chronic hepatitis C undergoing antiviral therapy.
- Collection of plasma and peripheral blood mononuclear cells (PBMCs).
- HCV genotyping performed on serum, PBMCs, and liver biopsy specimens using INNO-LiPA(TM) HCV II and confirmed by sequencing.
Main Results:
- Multiple HCV genotypes were identified in 2.3% of plasma, 6.8% of PBMCs, and 18.2% of liver biopsy samples.
- Significant discrepancies were noted in HCV genotypes detected between plasma, PBMCs, and liver biopsies.
- The genotypes found in PBMCs differed from those in plasma and liver biopsy specimens.
Conclusions:
- A notable proportion of chronic hepatitis C patients harbor multiple HCV genotypes.
- HCV genotyping solely from serum may not capture the full complexity of mixed infections.
- Liver biopsy and PBMC analysis can reveal HCV genotypes missed in plasma testing.
Aim:
To investigate the presence of mixed infection and discrepancy between hepatitis C virus (HCV) genotypes in plasma, peripheral blood mononuclear cells (PBMCs), and liver biopsy specimens.
Methods:
From September 2008 up to April 2009, 133 patients with chronic hepatitis C referred to Firouzgar Hospital for initiation of an antiviral therapy were recruited in the study. Five milliliters of peripheral blood was collected from each patient and liver biopsy was performed in those who gave consent or had indications. HCV genotyping was done using INNO-LiPA(TM) HCV II in serum, PBMCs, and liver biopsy specimens and then confirmed by sequencing of 5'-UTR fragments.
Results:
The mean age of patients was 30.3 +/- 17.1 years. Multiple transfusion was seen in 124 (93.2%) of patients. Multiple HCV genotypes were found in 3 (2.3%) of 133 plasma samples, 9 (6.8%) of 133 PBMC samples, and 8 (18.2%) of 44 liver biopsy specimens. It is notable that the different genotypes found in PBMCs were not the same as those found in plasma and liver biopsy specimens.
Conclusion:
Our study shows that a significant proportion of patients with chronic hepatitis C are affected by multiple HCV genotypes which may not be detectable only in serum of patients.
Related Concept Videos
Hepatitis
Viral Hepatitis I: Introduction
Genital Herpes
Cytomegalovirus Disease
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

